Post by
Gooseybear on Mar 06, 2023 10:32am
SGEN
Interesting article in WSJ about this company and working to gain approval for a drug that is to be combined with Keytruda to treat bladder cancer patients who have failed traditional treatments.
Comment by
Gooseybear on Mar 06, 2023 10:45am
Check the WSJ article on Yahoo Finance. It relates to drug companies that might be buyout targets. I wrote to the person who did the article explaining that there are other companies such as Theralase working on bladder cancer treatments for non responsive patients.
Comment by
Pandora on Mar 06, 2023 10:46am
Astellas, Seagen and Merck Announce FDA Acceptance of Supplemental Biologics License Applications for PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) for the First-Line Treatment of Certain Patients With Locally Advanced or Metastatic Urothelial Cancer PR Newswire December 20, 2022